ABSTRACT
Objective To investigate the effect of SP600125 on the proliferation, cell cycle, apoptosis and invasion of human cervical cancer HeLa cells. Methods CCK-8 method was used to detect the proliferation of HeLa cells treated with different concentrations of SP600125 at different time points. The 20 μmol/L of SP600125 was determined for subsequent experiments. Cell proliferation ability was detected using plate clone formation assay; nuclear morphology was observed by DAPI staining; cell cycle and apoptosis were measured by flow cytometry; cell migration and invasion were detected by cell scratch and Transwell methods; the mRNA and protein levels of p53, Mad2L1 and CDC20 were measured by qRT-PCR and Western blot after SP600125 treatment at different time points. Results Compared with control group (0.1%DMSO), cells proliferative activity were reduced by 10, 20, 30, 40 and 50 μmol/L SP600125 treatment for 24h. Compared with control group, the rate of apoptosis was significantly increased in SP600125 treatment groups, and the cell proportion in G2/M phase increased (P < 0.001), while the cell proportion in G0/G1 phases cells was reduced after SP600125 treatment for 24h and 48h (P < 0.001), and the clonal number, migration and invasion ability of HeLa cells also decreased significantly (P < 0.001). qRT-PCR and Western blot results showed a significant decrease in Mad2L1 mRNA and protein expression (P < 0.05) and a significant increase in p53 and CDC20 mRNA and protein expression (P < 0.01). Conclusion SP600125 can induce cell cycle arrest of cervical cancer HeLa cells in G2/M phase by upregulating p53 and CDC20 and downregulating Mad2L1 expression, and promote cell apoptosis to inhibit cell proliferation, migration and invasion.
ABSTRACT
Objective: To investigate and optimize the fermentation conditions of an ocean-derived fungus, Alternaria sp. 114- 1G, and isolate metabolites in the fermentation products to explore antitumor compounds in the products via the structure elucidation and in vitro antitumor activity assay. Another aim of this study is to accomplish a fundamental work for further research on new compounds from Alternaria sp. 114- 1G. Methods: The in vitro antitumor activity was assayed for the crude extracts and isolated compounds by the CCK-8 method using a human cervical cancer HeLa cell line. The fermentation conditions were investigated and opti- mized based on the biomass of the fermentation and the in vitro antitumor activity of crude extracts of the fermentation. For the separation and isolation of metabolites, the column chromatography was performed on silica gel and Sephadex LH-20 columns, and semi-preparative high performance liquid chromatography(semi-HPLC)was conducted on a COSMOSIL C18-MS-Ⅱ column(10 mm×250 mm). The obtained compounds were identified according to the MS, 1H NMR and13C NMR data. Results: The relatively favored fermentation conditions were as follows: mannitol 25 g/L, maltose 15 g/L, glucose 10 g/L, monosodium glutamate 10 g/L, soybean peptone 5 g/L, yeast extract 3 g/L; 60% sea water in whole medium, initial pH 7.5; and fermentation at 10℃ for 15 days under a 150 r/min shaking speed on a rotary shaker. Four compounds 1-4 were isolated from the fermentation products of 114-1G strain and identified as cyclo (Gla-Tyr)(1), cyclo(Ala-Ile)(2), thymidine DNA nucleotide(3)and pachybasin(4). Among them, 4 showed a relatively stronger inhibitory activity on HeLa cells, with the 57.8% of inhibition rate at 100 μg/ml. Some other compounds were also isolated, and a phenolic one had been shown to be a new compound by a literature survey according to the planar structure deduced. Further studies on their structures were in progress. Conclusion: Fermentation conditions for Alternaira sp. 114-1G were investigated preliminarily, and four compounds 1-4 have been isolated from the fermentation products of the 114-1G strain. Among them, pachybasin(4)showed a relatively higher inhibitory effect on human cancer HeLa cells. Alternaira sp. 114-1G could produce new metabolites and the present study has provided a reliable groundwork for further research on new compounds from Alternaira sp. 114-1G.
ABSTRACT
OBJECTIVE： To separate and purify Alhagi sparsifolia n-butanol extract monomeric compounds， and to investigate its effects on the proliferation and metastasis of human cervical cancer HeLa cells. METHODS： The n-butanol extract was separated and purified by silica gel column， Sephadex LH-20 gel column and prep-HPLC. The structures of compounds were analyzed and identified according to physicochemical properties and spectrum （mass spectrum， hydrogen spectrum， carbon spectrum） data. Using human cervical cancer HeLa cells as objects， 5-FU as positive control， MTT assay was used to detect the inhibitory rate of HeLa cells pretreated with different doses of compounds （6.25， 12.5， 25， 50， 100， 200 μg/mL）； IC50 was calculated to screen active monomers. Scratch test was used to investigate the effects of above active monomers （all 50 μg/mL） on the migration ability of HeLa cells. Kim’s formula was used to evaluate the effects of 5-FU separately combined with above active monomers [（3.125+6.25），（6.25+12.5），（12.5+25），（25+50）μg/mL]. RESULTS： Six compounds were isolated from the n-butanol extract part of A. sparsifolia and identified as butin （Ⅰ）， 3′，4′，7-trihydroxyisoflavone （Ⅱ）， p-methoxyphenylacetic acid （Ⅲ）， 4-hydroxyacetophenone （Ⅳ）， aurantiamide acetate （Ⅴ）， protocatechualdehydea （Ⅵ）. Compared with blank control group， 5-FU and each compound （5-FU：6.25-200 μg/mL， compound Ⅰ： 12.5-200 μg/mL； compound Ⅱ： 25， 50， 200 μg/mL； compound Ⅲ： 6.25， 100， 200 μg/mL； compound Ⅳ： 50， 100， 200 μg/mL； compound Ⅴ： 12.5， 25， 200 μg/mL； compound Ⅵ： 6.25-200 μg/mL） could significantly increase the cell inhibition rate. IC50 of compound Ⅰ， Ⅴ， Ⅵ were decreased significantly （P＜0.05 or P＜0.01）， and those of compound Ⅰ and Ⅵ were lower relatively. The migration distance of cells in 5-FU and compound Ⅰ and Ⅵgroups were decreased significantly， compared with blank control group （P＜0.05 or P＜0.01）. 5-FU separately combined with compound Ⅰ and Ⅵ showed additive and enhanced inhibitory effects on the proliferation of HeLa cells （synergistic index＞0.9）. CONCLUSIONS： Compounds Ⅰ-Ⅵ are isolated from Alhagi for the first time. Butin and protocatechualdehydea are active monomers of its n-butanol extract part. Above two monomers can inhibit the proliferation and migration of human cervical cancer Hela cells， with strong inhibitory effect in vitro， and stronger inhibitory effect combined with 5-FU than any compound alone.